Hoboken COVID-19 testing site moves indoors through new partnership

Office of Emergency Management Sgt. William Montanez, Dr. Raj Brahmbhatt, Director of Health and Human Services Leo Pellegrini, and Chris Mazzola of Bijou Properties outside of the new Riverside testing site .
×
Office of Emergency Management Sgt. William Montanez, Dr. Raj Brahmbhatt, Director of Health and Human Services Leo Pellegrini, and Chris Mazzola of Bijou Properties outside of the new Riverside testing site .

With colder weather fast approaching Hoboken, Mayor Ravi Bhalla, Dr. Raj Brahmbhatt of Riverside Medical, and local developer Bijou Properties have partnered to continue Riverside Medical Group’s COVID-19 testing for Hoboken residents at a new indoor location.

Riverside Medical Group will begin utilizing space donated to them, rent-free by Bijou Properties, including a 25,000 square foot warehouse and 30,000 square foot parking lot at 351 16th St., which will replace the testing site under the 14th Street Viaduct.

“Especially as the weather gets colder and we battle a second wave, we are honored to partner with the City of Hoboken and Riverside Medical Group to support our community and frontline workers during this challenging time,” said Larry Bijou, managing partner of Bijou Properties.

Hoboken residents and Riverside Medical Group patients without a vehicle can enter the new testing facility on Clinton Street between 15th and 16th streets.

Residents and patients driving to the facility should enter on 16th Street between Clinton Street and Grand Street.

The site will open on Saturday, Nov. 28, and the previous location under the 14th Street Viaduct will no longer be in operation.

Testing  is by appointment only for Hoboken residents, available at http://www.hobokennj.gov/riverside.

No walk-ins are permitted.

Hoboken residents who are Riverside Medical Group patients should call their Riverside primary care office for an appointment, and should not sign-up for a test online.

Riverside has provided 15,000 COVID-19 tests for Hoboken residents so far.

“Riverside Medical Group is thrilled to continue COVID-19 testing with Hoboken, and thanks Bijou Properties for providing space at a new location,” said Brahmbhatt. “We are proud to play a central role in Hoboken in providing one of the few rapid testing sites in the area, and the Bijou facility will help us continue to provide this service to residents and our patients.”

The city and Riverside first partnered in April to provide COVID-19 testing for Hoboken residents and has continued to do so since the start of the pandemic.

The Riverside site was one of the first public testing sites to offer rapid, 15-minute tests in the tri-state region, and one of the first to begin testing asymptomatic patients.

“On behalf of the City of Hoboken, I thank Bijou Properties, Dr. Brahmbhatt and their teams for facilitating testing at this new location, to help keep Hoboken residents safe,” said Bhalla.

“This new space will help protect the Riverside staff and residents during the winter weather, and provide more efficient testing for our City. Thank you also to our Office of Emergency Management, the Department of Health and the Department of Environmental Services for working throughout the week with the Riverside and Bijou teams on the new site, as well as Hudson County for providing the previous space under the 14thStreet Viaduct.”